Tyson A. Rietz

Fibrinogen in neurological diseases: mechanisms, imaging and therapeutics

Haemostatic materials for wound healing applications

CM-101: Type I Collagen–targeted MR Imaging Probe for Detection of Liver Fibrosis

Advances in functional and molecular MRI technologies in chronic liver diseases

Small vessel disease: mechanisms and clinical implications

A review of recent strategies for acid mine drainage prevention and mine tailings recycling

Red Blood Cell‐Facilitated Photodynamic Therapy for Cancer Treatment

Manganese Toxicity Upon Overexposure: a Decade in Review

What Is the Biological and Clinical Relevance of Fibrin?

Nanotechnology for Multimodal Synergistic Cancer Therapy

Single-nanometer iron oxide nanoparticles as tissue-permeable MRI contrast agents

Reactive oxygen species generating systems meeting challenges of photodynamic cancer therapy

Fast detection of liver fibrosis with collagen-binding single-nanometer iron oxide nanoparticles via T ₁ -weighted MRI

Chemistry of MRI Contrast Agents: Current Challenges and New Frontiers

A Manganese Alternative to Gadolinium for MRI Contrast

Hexameric Mn^II Dendrimer as MRI Contrast Agent

Effect of Chelate Type and Radioisotope on the Imaging Efficacy of 4 Fibrin-Specific PET Probes

3D molecular MR imaging of liver fibrosis and response to rapamycin therapy in a bile duct ligation rat model

Multisite Thrombus Imaging and Fibrin Content Estimation With a Single Whole-Body PET Scan in Rats

Fibrin-Targeted PET Probes for the Detection of Thrombi

Pycup—A Bifunctional, Cage-like Ligand for ⁶⁴Cu Radiolabeling

In Vivo Molecular Imaging of Thrombosis and Thrombolysis Using a Fibrin-Binding Positron Emission Tomographic Probe

Combined magnetic resonance elastography and collagen molecular magnetic resonance imaging accurately stage liver fibrosis in a rat model